TY - JOUR
T1 - Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use
AU - Dougherty, Donald M.
AU - Hill-Kapturczak, Nathalie
AU - Liang, Yuanyuan
AU - Karns, Tara E.
AU - Cates, Sharon E.
AU - Lake, Sarah L.
AU - Mullen, Jillian
AU - Roache, John D.
N1 - Funding Information:
Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [ R01AA14988 ]. The research was also supported in part by the National Institute of Drug Abuse [ T32DA031115 ] for postdoctoral training for Dr. Karns, Dr. Lake, and Dr. Mullen. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Dougherty also gratefully acknowledges support from a research endowment, the William and Marguerite Wurzbach Distinguished Professorship.
PY - 2014/9/1
Y1 - 2014/9/1
N2 - Background: Research on contingency management to treat excessive alcohol use is limited due to feasibility issues with monitoring adherence. This study examined the effectiveness of using transdermal alcohol monitoring as a continuous measure of alcohol use to implement financial contingencies to reduce heavy drinking. Methods: Twenty-six male and female drinkers (from 21 to 39 years old) were recruited from the community. Participants were randomly assigned to one of the two treatment sequences. Sequence 1 received 4 weeks of no financial contingency (i.e., $0) drinking followed by 4 weeks each of $25 and then $50 contingency management; Sequence 2 received 4 weeks of $25 contingency management followed by 4 weeks each of no contingency (i.e., $0) and then $50 contingency management. During the $25 and $50 contingency management conditions, participants were paid each week when the Secure Continuous Remote Alcohol Monitor (SCRAM-II™) identified no heavy drinking days. Results: Participants in both contingency management conditions had fewer drinking episodes and reduced frequencies of heavy drinking compared to the $0 condition. Participants randomized to Sequence 2 (receiving $25 contingency before the $0 condition) exhibited less frequent drinking and less heavy drinking in the $0 condition compared to participants from Sequence 1. Conclusions: Transdermal alcohol monitoring can be used to implement contingency management programs to reduce excessive alcohol consumption.
AB - Background: Research on contingency management to treat excessive alcohol use is limited due to feasibility issues with monitoring adherence. This study examined the effectiveness of using transdermal alcohol monitoring as a continuous measure of alcohol use to implement financial contingencies to reduce heavy drinking. Methods: Twenty-six male and female drinkers (from 21 to 39 years old) were recruited from the community. Participants were randomly assigned to one of the two treatment sequences. Sequence 1 received 4 weeks of no financial contingency (i.e., $0) drinking followed by 4 weeks each of $25 and then $50 contingency management; Sequence 2 received 4 weeks of $25 contingency management followed by 4 weeks each of no contingency (i.e., $0) and then $50 contingency management. During the $25 and $50 contingency management conditions, participants were paid each week when the Secure Continuous Remote Alcohol Monitor (SCRAM-II™) identified no heavy drinking days. Results: Participants in both contingency management conditions had fewer drinking episodes and reduced frequencies of heavy drinking compared to the $0 condition. Participants randomized to Sequence 2 (receiving $25 contingency before the $0 condition) exhibited less frequent drinking and less heavy drinking in the $0 condition compared to participants from Sequence 1. Conclusions: Transdermal alcohol monitoring can be used to implement contingency management programs to reduce excessive alcohol consumption.
KW - Contingency management
KW - Excessive alcohol use
KW - Transdermal alcohol monitoring
UR - http://www.scopus.com/inward/record.url?scp=84905576261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905576261&partnerID=8YFLogxK
U2 - 10.1016/j.drugalcdep.2014.06.039
DO - 10.1016/j.drugalcdep.2014.06.039
M3 - Article
C2 - 25064019
AN - SCOPUS:84905576261
SN - 0376-8716
VL - 142
SP - 301
EP - 306
JO - Drug and Alcohol Dependence
JF - Drug and Alcohol Dependence
ER -